Fundz

Anabios Closes Financing With Ampersand Capital Partners

PRIVATEJun 07, 2022

Round Type

Funding Round

San DiegoBiotechnologyCommunity And Lifestyle

Description

AnaBios Corporation, a leading preclinical contract research organization (CRO) that focuses on translational research with unique capabilities to measure drug activity directly in human tissue, today announced an investment from Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors.

Quick answer

Ana Bios raised an undisclosed amount in a Funding Round round, dated June 7, 2022. Ana Bios is based in San Diego, California, United States.

How much did Ana Bios raise?
Ana Bios raised an undisclosed amount in a Funding Round round on June 7, 2022.
What does Ana Bios do?
As a preclinical CRO, AnaBios has the most extensive network of hospitals and transplant centers for obtaining human tissue samples from ethically consented donors for ex vivo analysis.
Where is Ana Bios based and how big is it?
Ana Bios is based in San Diego, California, United States.

Source: Fundz verified event record.

Who else raised in Community And Lifestyle and Biotechnology around the same time

Companies in the same sectors as Ana Bios that raised within 45 days of this round, from Fundz verified event records.

  • Trait Biosciences Inc. raised $102K (Series A) on July 22, 2022.
  • BioLumic raised $14M (Series B) on June 21, 2022.
  • Massive Bio and Foundation Medicine raised $9M (Funding Round) on June 2, 2022.
  • Full Life Technologies raised $37M (Series A) on May 26, 2022.
  • Flyte Aviation, Inc. raised $6.2M (Funding Round) on July 22, 2022.
  • Leviathan Therapeutics raised $250K on July 22, 2022.

Who to call at Ana Bios, and when

A new round usually means Ana Bios is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ana Bios raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ana Bios, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ana Bios. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ana Bios

Location

San Diego, California, United States

About

As a preclinical CRO, AnaBios has the most extensive network of hospitals and transplant centers for obtaining human tissue samples from ethically consented donors for ex vivo analysis. "AnaBios is thrilled to partner with Ampersand to elevate our business in the growing pharma industry," said Dr. Andre Ghetti, CEO of AnaBios.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ana Bios raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Ana Bios's next move

See what Strategic adds

Ana Bios raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.